Therapy for isocitrate dehydrogenase 2 (IDH2)(R172) -mutant acute myeloid leukaemia. Linch DC, Hills RK, Burnett AK, Russell N, et al. Br J Haematol 2022;196:1348-1352.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Linch DC, Hills RK, Burnett AK, Russell N, et al. Therapy for isocitrate dehydrogenase 2 (IDH2)(R172) -mutant acute myeloid leukaemia. Br J Haematol 2022;196:1348-1352.
PMID: 34870324